It was the best of times, it was the worst of times, it was the age of wisdom, it was the age of foolishness, it was the epoch of belief, it was the epoch of incredulity, it was the season of light, it was the season of darkness, it was the spring of hope, it was the winter of despair, we hadPhiladelphia asked Benjamin Franklin, "Well, Doctor, what have we got, a republic or a monarchy?" With no hesitation whatsoever, Franklin responded, "A republic, if you can keep it." ~ BENJAMIN FRANKLIN 1787
The week in whoppers: Joy Reid’s ugly slurs, WaPo’s scaremongering and more
By
Post Editorial Board
MSNBC host Joy Reid claimed that Elon Musk misses apartheid in South Africa. NY Post composite / istock/ Getty Images
Diary of disturbing disinformation and dangerous delusions
This slur:
“[Elon Musk and the right] want to . . . be able to punch people in the face . . . and laugh about it. . . . I guess [Musk] misses the old [apartheid] South Africa.”
— MSNBC host Joy Reid, April 26
We say: Reid blasts Elon Musk and conservatives for wanting to “harass,” “punch people in the face” and spread misinformation on Twitter. But in making such an outrageous suggestion, she herself is engaging in precisely the kind of ugly, slanderous attacks she accuses Musk of waging. Do talking heads like Reid ever listen to themselves?
Only days after White House visitor logs revealed then-Vice President Joe Biden had met with Hunter Biden’s business associate while in office, new emails report Biden may have paid legal fees for his son’s Chinese deals and raise further questions as to a discrepancy of over $5 million in financial reports.
The documents, exclusively obtained by the Daily Mail, focus on government transparency reports submitted to the Office of Government Ethics (OGE) and a January 2019 email from Hunter’s assistant, Katie Dodge.
Daily Mail compared the OGE filings of Biden representing 2017 – 2019 and found a discrepancy of around $5.2 million in reported income from his firm CelticCapri, used for speaking and writing engagements, when compared to his IRS tax returns.
They went on to report, under the subject line “Hunter’s bills,” Dodge reached out to book-keeper Linda Shapero, Biden aide Richard Ruffner, and Hunter to discuss an arrangement the former vice president had made to cover hundreds of thousands of bills for his son.
“Hello VP team,” the email acquired by Daily Mail began. “I spoke with Hunter today regarding his bills. It is my understanding that Hunt’s dad will cover these bills in the short-term as Hunter transitions in his career. I have a list of the current bills of which I am aware. I have attached the list below….”
The attached list totaled $737,130.61 in bills, including one for $28,382 listed as “Faegre Baker Daniels: BHR Restructuring,” due ASAP. BHR or Bohai Harvest RST is the private equity firm that as of March 2022, Hunter Biden still appeared to be a part-owner of through the LLC Skaneateles.
Hunter’s lawyer George Mesires, who would not comment on the younger Biden’s continued connection to the Chinese firm, is a partner with Faegre Baker Daniels, now known as Faegre Drinker.
As Daily Mail noted, the same year Joe Biden is alleged to have taken responsibility for these bills is when he made the campaign promise, “No one in my family will have an office in the White House, will sit in on meetings as if they are a cabinet member, will, in fact, have any business relationship with anyone that relates to a foreign corporation or a foreign country. Period. Period. End of story.”
The revelation that the president and his aides had met with Hunter’s business associate Eric Schwerin near-to or leading up to meetings with Chinese officials brings back the question of the “10 percent” of Hunter’s earnings that were believed to be going to Biden.
As reported, “This was the deal for which Joe Biden was to get a 10% cut, as cited in an infamous 2017 email on the laptop. ’10 [percent] held by H [Hunter] for the big guy.”
Though there is no conclusive evidence that the monies left out of the OGE report may be associated with Hunter Biden’s foreign business dealings, the credibility of the president remaining distanced from his son’s arrangement continues to wither.
A FAIRY TALE OF DISNEY PROPORTIONS
Sen. Chuck Grassley (R-Iowa) told the Mail, “Evidence of the president’s financial and business connections to Hunter continues to grow. It’s imperative for the first family to show the American people the transparency that they deserve.”
Hunter Biden Wrote Furious Letter To Father After Trump’s Win
(FreedomBeacon.com)- Hunter Biden, the President of the United States’ son, wrote a scathing letter to his father just days before Donald J. Trump was sworn in as the 45th President of the United States as Biden accepted the Presidential Medal of Freedom and refused, in Hunter’s words, to credit his family for his life’s work properly.
I'M THE BIRD THAT CRAPPED ON DAD!
The message comes from Hunter’s notes app, and explains a peculiar familial structure that positions Joe Biden at the top, like a mafia crime boss, from the “hard drive from hell.” Here is an excerpt:
Dad you have to listen- then you can do whatever you want. I’ll make it the last time and you can ignore it or I hope at least acknowledge that the three people On earth who have lived their lives in service to you who love you more than the next 30 combined have suddenly all concluded for their own reasons that you have finally crossed the line- that we won’t be publicly and privately humiliated while those that publicly and privately humiliate us our [sic] held to the world as the loves of your life the life of your…
Love is an action dad not an emotion. Think how your brother and sister express their love for you. They do anything you tell them to do and have their whole lives. You act as if I have no right to tell you about what you did or didn’t have or haven’t done with your siblings. Well that’s just absurd. Uncle Jimmy is my best friend and aunt Val is my mother – and if you make me ever feel like saying that is somehow la [sic] betrayal than [sic] know this every time over the last 30 years you say “she saved OUR lives” with aunt Val standing right next and never mention her I feel like grabbing the mic and saying she may have saved his life but beau and I were pretty happy with Mom mom and Aunt Val. Loosing Mommy was more like expect it might be to be born without legs you know something really really important isn’t there but don’t quite know why it feels so incredibly absent when you can’t remember it’s presence.
What is evident is the Biden family’s dissatisfaction with Joe Biden’s “service” throughout his political career, at least as seen through Hunter’s eyes.
Hunter’s letter is not the only one written by a Biden that sheds light on the Biden clan corruption.
President Biden maintains that he never discussed the Biden family business with his son Hunter, i.e., the business in which Hunter and the president’s brother Jim have profited for decades from Joe’s political clout, particularly in corrupt and authoritarian countries, including those hostile to American interests. According to the most recent information on the subject, Biden prepared a letter of reference for one of Hunter’s Chinese business associates in 2017 to get the partner’s kid admitted to Brown University.
According to a check of emails from Hunter Biden’s laptop, Jonathan Li reached out to Hunter and his American business partners Devon Archer and James Bulger at the start of 2017, seeking help to enhance Li’s son Christopher’s college applications. He was applying to two Ivies, Brown and Cornell, and another prestigious institution, New York University, where acceptance is extremely tough.
Li was a partner at Bohai Capital, a Chinese private equity firm. He joined Hunter in a successful enterprise called Bohai Harvest RST. Hunter caught a trip on Air Force Two with his father, then-Vice President Joe Biden, traveling to Beijing on behalf of the Obama administration for talks with President Xi in 2013. Hunter met with Li and arranged for him to shake hands with Vice President Biden, according to a report released by Republican senators Chuck Grassley and Ron Johnson. Beijing granted the enterprise a license shortly after the trip.
VOTING IN PERSON IN MOST COUNTRIES USES THE ABOVE METHOD TO PROVIDE INTEGRITY FROM VOTING MORE THAN ONCE ... SIMPLE ISN'T IT. THIS METHOD DOESN'T WORK WITH MAIL-IN VOTING, IDENTIFICATION, AND CITIZENSHIP BUT BLOCKCHAIN TECHNOLOGY WILL PROVIDE INTEGRITY IN THE ISSUANCE OF THE PAPER BALLOT AND SUBSEQUENT COUNTING ONLY OF A LEGAL VOTE.
Florida Gov. Ron DeSantis (R) signed a bill into law on Monday creating a law enforcement unit to protect election integrity and increase penalties for certain voting violations.
“I don’t think there’s any place in the country where you should have more confidence that your vote counts than in the State of Florida,’ DeSantis said at the bill’s signing.
Florida Senate Bill 524 created the Office of Election Crimes and Security under Florida’s State Department. The newly created office is allowed to review allegations of voter fraud and conduct preliminary investigations into the allegations.
Before this law, Florida’s governor could appoint officers to investigate alleged violations of state election law. According to the AP, it is now mandatory for the governor to select a group of special officers from the Florida Department of Law Enforcement to handle election law violations.
The law also designated ballot harvesting as a third-degree felony, increased fines for certain election law violations, and mandated more frequent maintenance of the state’s voter list.
DeSantis said a dedicated law enforcement unit is necessary because some members of the police force “may not care as much about the election stuff.”
“Some of them may not care as much about the election stuff. I think it’s been mixed at how those reactions are going to be. So we just want to make sure whatever laws are on the books, that those laws are enforced,” he said.
The new Florida law comes as DeSantis and other Republicans nationwide are focused on securing election integrity following claims that the 2020 presidential election was ripe with voter fraud. It also comes after U.S. District Judge Mark Walker struck down a Florida law that would have limited the times individuals could submit their ballots at drop boxes.
After Elon Musk buys Twitter, Jack Dorsey will return as CEO
According to reports, after Tesla CEO, Elon Musk successfully acquires Twitter, the former CEO Jack Dorsey will return as CEO. Recall that Jack Dorsey only recently left his position as CEO. Twitter announced earlier today that it had reached a definitive agreement with Musk on the acquisition. Musk will buy Twitter for $54.20 per share in cash, in a deal valued at about $44 billion. The transaction is expected to close by the end of this year. At that time, Twitter will be delisted from the New York Stock Exchange and become a private company.
While the deal had been in the works for about two weeks, it was still in the dark until it was announced Monday afternoon. There may be more than 440 questions to be asked about Twitter’s future. These include whether Twitter employees will have jobs after the deal closes and whether Musk will move Twitter’s headquarters out of San Francisco.
But the most pressing question is: Who will run Twitter under Musk? Could this be Dorsey, the two-time Twitter CEO? First, let’s rule out some potential options. Currently, Musk is also in charge of Tesla and SpaceX, the space exploration technology company. This obviously reveals that he will not spend a lot of time on Twitter.
In addition, Twitter’s current CEO, Parag Agrawal, does not seem eager for the position. After all, Musk said in his initial take-private offer to Twitter that “I have no confidence in the management”. Therefore, it is possible that Musk will no longer let Agrawal run Twitter.
This reminds us of Dorsey. It sounds crazy, right? Dorsey, who just stepped down as Twitter CEO last November, is obsessed with bitcoin. But Dorsey’s name was frequently mentioned in this acquisition. Those who know Twitter will not ignore him completely.
First, he and Musk have a great relationship. In early 2020, Musk appeared in a video at Twitter’s all-hands meeting, where Dorsey interviewed him in front of employees and asked him how he could “fix” Twitter. Last year, at the invitation of Dorsey, the two appeared at a bitcoin conference at the same time.
When Musk was invited to serve on Twitter’s board of directors earlier this month (which he ultimately declined), Dorsey said on Twitter that he wanted Musk to be a long-term Twitter director. In 2019, Dorsey said of Musk: “I like him, I like what he’s trying to do, and I want to help in any way I can.”
When it comes to Twitter’s products, the duo have a lot of similar ideas. Most notably, they argue that the algorithms that power Twitter feeds should be more transparent and open source. In addition, both are aware of Twitter’s problems with controlling user speech.
Dorsey, a co-founder of Twitter, left Twitter in late 2008 to create Square, a digital payments company. However, in 2015, Dorsey was ordered to return to Twitter as CEO. Dorsey subsequently announced his resignation again last November.
Once Musk’s acquisition of Twitter is completed, Twitter will become a private company. Of course, Dorsey seems distracted at times and may not be a very good operator. However, he’s still the co-founder of Twitter, and whoever owns Twitter will always have influence.
Regarding Musk’s successful acquisition of Twitter, Dorsey said on Twitter today: “I love Twitter, it is the closest thing we have to global awareness. Its concept and service are very important to me, and I will do everything I can. to maintain these.”
In a January 2021 lecture, Jonathan Latham, Ph.D., introduced the term “the pandemic virus industrial complex,” to describe the academic, military and commercial complexes that are driving the pandemic agenda and obscuring facts that indicate SARS-CoV-2 is a manmade virus.
In the video above, David E. Martin, Ph.D., introduces shocking evidence that SARS-CoV-2 is indeed a manmade bioweapon, and has been in the works for decades. Much of this research was funded by none other than the National Institutes of Allergy and Infectious Diseases (NIAID) under the direction of Dr. Anthony Fauci.
Pandemic virus industrial complex indeed! You do not want to miss this bombshell interview, conducted by Reiner Fuellmich,1 founding member of the German Corona Extra-Parliamentary Inquiry Committee2,3 (Außerparlamentarischer Corona Untersuchungsausschuss or ACU4). A transcript5 is available if you prefer to read it.
SARS-CoV-2 Is Not a Novel Coronavirus at All
Martin has been in the business of tracking patent applications and approvals since 1998. His company, M-Cam International Innovation Risk Management, is the world’s largest underwriter of intangible assets used in finance in 168 countries. M-Cam has also monitored biological and chemical weapons treaty violations on behalf of the U.S. government, following the anthrax scare in September 2001.
According to Martin, there are more than 4,000 patents relating to the SARS coronavirus. His company has also done a comprehensive review of the financing of research involving the manipulation of coronaviruses that gave rise to SARS as a subclade of the beta coronavirus family.
In his testimony to ACU, he reviews some of the most pertinent patents, showing SARS-CoV-2 is not a novel coronavirus at all but, rather, a manmade virus that has been in the works for decades.
A comprehensive list of 120 patents relating to SARS-CoV-2-associated features can be found here.6 The features patented are referenced in two key scientific papers, “A Novel Bat Coronavirus Reveals Natural Insertions at the S1/S2 2 Cleavage Site of the Spike Protein and a Possible Recombinant 3 Origin of HCoV-19,” and “The Proximal Origin of SARS-CoV-2.” In case the URL is: https://www.m-cam.com/wp-content/uploads/2020/04/20200403_SARS_CoV_Patent_Corpus_Lit_Review.pdf
On that list, we see numerous patents detailing manipulation of the polybasic cleavage site for SARS-CoV, the spike protein, as well as ACE2 binding, all three of which are supposed to be unique features of SARS-CoV-2. As explained by Martin:
“We took the reported gene sequence, which was reportedly isolated as a novel virus, indicated as such by the ICTV, the International Committee on Taxonomy of Viruses of the World Health Organization. We took the actual genetic sequences that were reportedly novel and reviewed those against the patent records that were available as of the spring of 2020.
And what we found, as you’ll see in this report, are over 120 patented pieces of evidence, to suggest that the declaration of a ‘novel coronavirus’ was actually entirely a fallacy.
There was no novel coronavirus. There are countless, very subtle modifications of coronavirus sequences that have been uploaded, but there was no single identified ‘novel coronavirus’ at all.
As a matter of fact, we found records in the patent records, of sequences attributed to novelty, going to patents that were sought as early as 1999. So not only was this not a novel anything … it’s not been novel for over two decades.”
Spike Protein Vaccine for Coronavirus Patented 22 Years Ago
Up until 1999, coronavirus patents were all in the veterinary sciences. The first coronavirus vaccine to use the S spike protein was patented by Pfizer in January 2000 (Patent No. 6372224). It was a spike protein virus vaccine for canine coronavirus. You can look up the actual patents for yourself on the United States Patent and Trademark Office’s website,7 if you like.
“Ralph Baric’s work on … rabbit cardiomyopathy … and then canine coronavirus in Pfizer’s work, to identify how to develop S spike protein vaccine target candidates, [give] rise to the obvious evidence that …
… neither the coronavirus concept of a vaccine, nor the principle of the coronavirus itself, as a pathogen of interest with respect to the spike proteins behavior, is anything novel at all. As a matter of fact, it’s 22 years old based on patent filings,” Martin says.
From HIV Vaccine Development to COVID-19
According to Martin, Fauci and the NIAID “found the malleability of coronavirus to be a potential candidate for HIV vaccines,” and in 1999, Fauci funded research at University of North Carolina Chapel Hill (where Baric has a lab) to create “an infectious replication-defective coronavirus” specifically targeted for human lung epithelium.
The patent for that replication-defective coronavirus that attacks human lung cells was filed April 19, 2002 (Patent No. 7279327). “In other words, we made SARS,” Martin says. Or perhaps more accurately, Fauci and UNC did. Several months after that patent filing, the SARS outbreak in Asia occurred.
“That patent, issued as U.S. Patent 7279327 … clearly lays out in very specific gene sequencing, the fact that we knew that the ACE receptor, the ACE2 binding domain, the S-1 spike protein, and other elements of what we have come to know as this scourge pathogen, was not only engineered, but could be synthetically modified in the laboratory using nothing more than gene sequencing technologies.
Taking computer code and turning it into a pathogen, or an intermediate of the pathogen, and that technology was funded exclusively, in the early days, as a means by which we could harness coronavirus as a vector to distribute HIV vaccine.”
Coronavirus — A Biological Weapon Candidate Since 2001?
As mentioned, Martin has monitored biological and chemical treaty violations since 2001, following the anthrax attacks. Throughout the fall of 2001, an “enormous number” of bacterial and viral pathogens were patented through the National Institutes of Health, the NIAID, the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and their international collaborators.
“Our concern was that coronavirus was being seen as not only a potential manipulatable agent for potential use as a vaccine vector, but it was also very clearly being considered as a biological weapon candidate,” Martin says.
Before the SARS outbreak in China, Martin reported these concerns publicly. “So, you can imagine how disappointed I am to be sitting here … having 20 years earlier pointed that there was a problem looming on the horizon with respect to coronavirus,” he says.
CDC Holds Patents on SARS Coronavirus
In April 2003, after the SARS outbreak in China had occurred, the U.S. Centers for Disease Control and Prevention tried to file a patent for the entire gene sequence for the SARS coronavirus (Patent No. 7220852). This is a violation of 35 U.S. Code Section 101, which states you cannot patent a naturally-occurring substance.
That CDC patent also had several derivative patents associated with it, including U.S. patent 46592703P and U.S. patent 7776521. These two patents cover the gene sequence of SARS coronavirus and the means for detecting it using RT PCR testing.
Together, these patents are highly problematic, because if you own both, then “you have a cunning advantage to being able to control 100% of the provenance of not only the virus itself, but also its detection, meaning you have entire scientific and message control,” Martin explains.
The CDC tried to justify the patent by saying they were being sought in order to ensure that everyone would be free to research coronaviruses. However, that is a lie, Martin says. The U.S. patent office rejected the patent on the gene sequence as unpatentable because it was 99.9% identical to a coronavirus that was already in the public domain.
The CDC paid an appeal fine in 2006 and again in 2007. They also paid an additional fee to keep the application private. In the end, the CDC overrode the patent examiner’s rejection and secured the patent in 2007.
“Last time I checked, if you’re trying to make information available for the public research, you would not pay a fee to keep the information private,” Martin says. According to Martin, the gene sequence filed by the CDC in 2003, 2005 and 2006 is 89% to 99% identical to the sequence identified as SARS-CoV-2.
Sequoia Pharmaceuticals
April 28, 2003 — three days after the CDC filed its patent for the SARS coronavirus — Sequoia Pharmaceuticals filed a patent on an antiviral agent for the treatment and control of infectious coronavirus (Patent No. 7151163). So, the CDC files a patent on SARS coronavirus, and three days later there’s a treatment?
This strongly suggests there was a working relationship behind the scenes. Sequoia Pharmaceuticals, founded in 2002, develops antiviral therapeutics with a special focus on drug-resistant viruses.8 Its lead investors include the Wellcome Trust.
But there’s yet another problem with Sequoia’s 2003 filing for an antiviral agent. It was actually issued and published before the CDC patent on SARS coronavirus had been granted, which didn’t happen until 2007, and the CDC had paid to keep the application private.
“So, the degree to which the information could have been known by any means other than insider information between those parties is zero,” Martin says. “It is not physically possible for you to patent a thing that treats a thing that had not been published, because CDC had paid to keep it secret.
This, my friends, is the definition of criminal conspiracy, racketeering and collusion. This is not a theory, this is evidence. You cannot have information in the future, and form a treatment for a thing that did not exist. It is a RICO case …
And the RICO pattern, which was established in April of 2003 for the first coronavirus, was played out to exactly the same schedule when we see SARS COV-2 show up, when we have Moderna getting the spike protein sequence by phone from the vaccine research center at NIAID, prior to the definition of the novel subclade. How do you treat a thing, before you actually have the thing?”
Sanofi Holds Patents to Novel Feature of SARS-CoV-2
The next bombshell revelation occurred on June 5, 2008, when Ablynx, now a part of Sanofi, filed a series of patents detailing what we’ve been told are novel features of SARS-CoV-2, namely the polybasic cleavage site, the spike protein and the ACE2 receptor binding domain. The first of those patents, U.S. Patent No. 9193780, was issued November 24, 2015.
Between 2016 and 2019, a series of patents were issued to Ablynx and Sanofi covering the RNA strands and the subcomponents of the gene strands.
Between 2008 and 2017, a series of patents were also filed by a long list of players, including Crucell, Rubeus Therapeutics, Children’s Medical Corporation, Ludwig-Maximilians-Universität in München, Protein Science Corporation, Dana-Farber Cancer Institute, University of Iowa, University of Hong Kong and the Chinese National Human Genome Center in Shanghai.
This series of patents detail ever single attribute that is supposed to be unique to SARS-CoV-2, according to the paper, “A Novel Bat Coronavirus Reveals Natural Insertions at the S1/S2 2 Cleavage Site of the Spike Protein and a Possible Recombinant 3 Origin of HCoV-19.”
This paper has routinely been used to identify the so-called novel coronavirus that is SARS-CoV-2. Yet there are 73 patents, issued between 2008 and 2019, that describe the very elements that are said to be unique to SARS-CoV-2. Patents have been filed for SARS-CoV-2’s polybasic cleavage site, the ACE2 receptor binding domain, and the spike protein.
“So, there was no ‘outbreak’ of SARS, because we had engineered all of the elements of that,” Martin says. And by 2016, when Baric published a paper warning that SARS coronavirus was “poised for human emergence,” the virus in question had already been patented for commercial exploitation 73 times!
The Pandemic Virus Industrial Complex Is Swimming in Profit
Baric is one of the few people who has profited significantly from this pandemic, which he appears to have been part of creating. Another is Fauci. The same drug companies that hold patents on not-so-novel SARS-CoV-2 features are also raking in profits from their COVID shots.
In 2015, Dr. Peter Daszak, head of the EcoHealth Alliance that funneled research dollars from the NIAID to the Wuhan Institute of Virology for coronavirus research, who has promoted the official narrative that SARS-CoV-2 has a natural origin, stated:9
“We need to increase public understanding of the need for medical countermeasures such as a pan-coronavirus vaccine. A key driver is the media and the economics will follow the hype. We need to use that hype to our advantage, to get to the real issues. Investors will respond if they see profit at the end of the process.”
Sounds an awful lot like what we’re facing right now, doesn’t it? At the end of the day, this pandemic has primarily been about profit and the shifting of wealth, from the lower- and middle-classes to the already ultra-wealthy. This is a war on the public, waged using biological weapons and information warfare, with the ultimate goal of “resetting” life and commerce as we know it.
Intentional Weaponization of Spike Protein
Martin says:
“There wasn’t a lab leak. This was an intentional bio-weaponization of spike proteins to inject into people, to get them addicted to a pan-coronavirus vaccine. This has nothing to do with a pathogen that was released, and every study that’s ever been launched to try to verify a lab leak, is a red herring.
[There are] 73 patents on everything clinically novel — 73, all issued before 2019. And I’m going to give you the biggest bombshell of all to prove that this was actually not a release of anything, because Patent No. 7279327, the patent on the recombinant nature of that ‘lung-targeting’ coronavirus, was transferred mysteriously from the University of North Carolina Chapel Hill to the National Institutes of Health in 2018.
Now, here’s the problem with that. Under the Bayh-Dole Act, the U.S. government already has what’s called a march-in right provision. That means if the U.S. government has paid for research, they are entitled to benefit from that research at their demand or at their whim.
So, explain why, in 2017 and 2018, suddenly the National Institutes of Health have to take ownership of the patent that they already had rights to, held by the University of North Carolina Chapel Hill. And how did they need to file a Certificate of Correction to make sure that it was legally enforceable, because there was a typographical error in the grant reference in the first filing?
They needed to make sure that not only did they get it right, but they needed to make sure every typographical error that was contained in the patent was correct on THE SINGLE PATENT REQUIRED, to develop the Vaccine Research Institute’s mandate, which was shared between the University of North Carolina Chapel Hill and Moderna in November of 2019, when UNC Chapel Hill, NIAID and Moderna began the sequencing of a spike protein vaccine — a month before an outbreak ever happened.”
‘New Normal’ Coined by Merck at 2004 Bioterrorism Conference
The more we learn, the grimmer it gets. Clearly, plans for our current-day predicament were laid well over a decade ago. According to Martin, the slogan “The New Normal” was coined by Merck during a January 6, 2004, conference called “SARS and Bioterrorism, Emerging Infectious Diseases, Antimicrobial Therapeutics, and Immune Modulators.”
This term has now become a branded campaign adopted by the World Health Organization, the Global Preparedness Monitoring Board and the rest of the pandemic virus industrial complex.
Incidentally, Fauci is on the board of directors of the Global Preparedness Monitoring Board, as is Dr. Chris Elias, president of the Global Development Program at the Bill & Melinda Gates Foundation, and George Fu Gao, Ph.D., director-general of the Chinese CDC and a Chinese communist party member.10
It’s a long interview, but it does not disappoint. I urge you to take the time to listen to it, as Martin really lays out the timeline of when and how this pandemic virus came to be. He’s also published a 205-page paper11 detailing Fauci’s involvement that you can download from archive.org.
It now seems clearer than ever that everything we’re experiencing was planned and executed with a profit motive in mind. Armed with this new knowledge, I urge you once again to reclaim your life, your freedom and independence, and resist this manufactured notion of a “new normal.” A new normal will surely be established if we persist, but it will be the converse of what the pandemic virus industrial complex is hoping for.
We will resurrect medicine and science from the induced coma these fields are currently in, and usher in a new era of medical freedom, personal liberty, responsible and transparent government, fiscal stability and health care that actually promotes health rather than slow death. It may take a while, but together, we can do it. To get there, keep sharing information such as that provided by Martin in this mind-blowing interview in any way you can. In the end, truth will prevail. Believe it.
The carrier is focused on using its C-Band spectrum for improved 5G, but it's feeling the pressure from rivals, its earnings report shows.
IT'S A BRAVE NEW WORLD ... I STILL USE A FLIP PHONE!
Sarah Tew/CNET
Verizon is feeling the competitive heat. The nation's largest wireless carrier suffered a decline in the first quarter and warned that its earnings growth would be at the lower end of its previous expectations.
Verizon lost 292,000 consumer postpaid phone subscriptions, the metric used by the industry as an indicator of success. In a Friday press release on its earnings for the quarter, Verizon chalked the loss up to "competitive dynamics." On Thursday, rival AT&T reported first-quarter subscriber gains.
Verizon's losses were largely offset by 256,000 business postpaid phone net additions, but the carrier is still concerned about the consumer losses, which mostly happened in March, when the first quarter closed, and into April, suggesting additional slowdown in the second quarter.
"We will continue to take appropriate measures to be competitive in the market," Verizon Executive Vice President and Chief Financial Officer Matt Ellis said during the earnings call, though he didn't offer specifics beyond comments about relying on the carrier's network and flexible plans.
Still, overall wireless services revenue was up 11.2% over last year, thanks in part to existing customers moving to pricier plans, as well as revenue from prepaid mobile company Tracfone, which appeared on Verizon's books for the first time after the carrier finished acquiring the company last November. Verizon reported a loss of 80,000 Tracfone net phone subscriptions over the quarter, which the carrier pegged to the sunsetting of generous pandemic mobile service subsidies that benefited the prepaid company's customer base.
Verizon's focus on wireless and broadband internet may take some time to attract more customers and offset losses, especially as it spends this year building out coverage of its so-called C-band range of 5G, which launched in January. The carrier is betting big on C-band radio frequencies as a lure for customers, with higher speeds and wider coverage of its 5G Ultra Wideband network. But this quarter's losses suggest customers aren't yet convinced.
After reaching C-band 5G coverage of 100 million people in January, Verizon has continued to activate more service and is on track to reach 175 million people by the end of 2022. At Verizon's investor day in March, the carrier said it had reached agreements with satellite companies to access more C-band spectrum, which will speed up coverage of 40 million people in certain markets, a year ahead of Verizon's expectations.
Verizon has continued encouraging its existing customers to upgrade their phones, and 40% of customers are now using 5G handsets. That's not much higher than the 33% reported in January. Numbers will slowly grow over the next year, with the carrier expecting six out of 10 customers to be using 5G phones by the end of 2023.
Verizon's Fios fixed broadband added a modest 55,000 subscribers while its fixed wireless access, called Verizon 5G Home, continues to grow, with 112,000 net new customers. The carrier credited this to the wider availability of 5G Home thanks to the continued rollout of C-band service. Under current expansion plans, the service will cover 50 million households and 14 million businesses by the end of 2025.
Verizon posted $33.6 billion in revenue in the first quarter, up 2.1% from the same period last year. With Tracfone in its portfolio, wireless revenue grew to $15.2 billion, up from $13.7 billion in the first quarter of 2021. This is partially offset by the lost revenue from Verizon Media Group, sold last year, which dropped service and other revenue by 2.5%.
The carrier reported net income of $4.7 billion, or earnings of $1.09 per share. Its adjusted earnings came in at $1.35 per share, which is in line with analyst expectations per Yahoo Finance, but down slightly from $1.36 a share a year ago.
Verizon shares fell 6.2% to $51.60 in recent trading.
